BIIB

Biogen
D

BIIB

Arincen57/100B

Biogen P/E ratio

Biogen's P/E ratio is 106.56: its share price of 251.47 over its earnings per share of 2.36 over the last twelve months.

Today
106.56
Forward P/E, next 12 months
15.97
PEG ratio
5.85
Median, 5 years
17.55
Low, 5 years
10.11
High, 5 years
108.00

P/E ratio = price ÷ EPS (last 12 months) = 251.47 ÷ 2.36 = 106.56

Each day's closing price over the earnings per share of the last four quarters reported by that day (basic EPS, adjusted for splits). The P/E moves with the price every day and with the earnings at each report.

The forward P/E divides the price by the analysts' average EPS estimate for the next twelve months: the fiscal year in progress for the months left in it, the next one for the rest. For past days it uses each year's latest estimate, as the estimates of the time were not recorded (we keep a daily copy from November 2026), so the past line reads the price against the earnings expected by the time each year was reported.

Is Biogen's P/E high compared with its own history?

Biogen's P/E of 106.6 is near the top of its 5-year range (10.1 to 108.0, median 17.6). It is within 5% of its 5-year high. Analysts expect faster growth than in recent years, which can explain part of the high P/E.

Is the price fair? See the whole check

A P/E is compared with the stock's own last five years, not with other companies. Why the market pays more or less (news, rates, the sector) is not in these figures.

P/E ratio by year and by quarter

Fiscal yearPeriod endingP/E ratioForward P/EMarket capNet income
FY2027 · Estimate31 Dec 202715.49———
FY2026 · Estimate31 Dec 202620.11———
Today106.5615.9737.17B-69.50M
FY202531 Dec 202519.9714.0825.82B1.29B
FY202431 Dec 202413.6510.2422.28B1.63B
FY202331 Dec 202332.2415.8237.44B1.16B
FY202231 Dec 202213.5918.4540.24B2.96B
FY202131 Dec 202120.7114.0335.77B1.73B
FY202031 Dec 20209.7012.7539.40B4.06B
FY201931 Dec 20199.438.7855.52B5.89B
FY201831 Dec 201813.789.0461.66B4.47B
FY201731 Dec 201725.3710.0967.73B2.67B
FY201631 Dec 201616.7610.0961.93B3.70B
FY201531 Dec 201519.6715.1970.67B3.59B
FY201431 Dec 201427.2816.8380.23B2.94B
FY201331 Dec 201335.5724.2366.24B1.86B
FY201231 Dec 201225.2421.2734.83B1.38B
FY201131 Dec 201121.0619.4126.68B1.27B
FY201031 Dec 201018.8311.7816.92B898.57M
FY200931 Dec 200915.7312.6215.37B977.06M
FY200831 Dec 200817.7813.9313.92B783.17M
FY200731 Dec 200728.1717.3017.98B638.17M
FY200631 Dec 200676.5718.8116.65B217.51M
FY200531 Dec 200594.5525.5915.20B160.71M
FY200431 Dec 2004889.5040.3722.31B25.09M
FY200331 Dec 2003—27.3912.25B0.00
FY200231 Dec 200264.9524.7512.94B199.15M
FY200131 Dec 200198.5887.2526.88B272.68M
FY200031 Dec 200084.53107.4028.20B333.58M
FY199931 Dec 199966.82112.9314.73B220.45M
FY199831 Dec 199849.9625.276.93B138.70M
FY199731 Dec 199756.41143.255.03B89.17M
FY199631 Dec 199683.01—3.36B40.53M
FY199531 Dec 1995404.81—2.29B5.66M
FY199431 Dec 1994——289.00M-4.90M
FY199331 Dec 199322.12—716.54M32.40M
FY199231 Dec 199231.25—1.20B38.30M
FY199131 Dec 1991203.13—1.46B7.20M
FY199031 Dec 1990219.16—1.69B7.70M
FY198931 Dec 1989380.86—1.22B3.20M
FY198831 Dec 1988——750.00M-1.20M
FY198731 Dec 1987——1.63B-22.60M
FY198631 Dec 1986——1.47B-28.20M
FY198531 Dec 1985——1.38B-19.10M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters. A forecast year's P/E is today's price over the analysts' EPS estimate for that year.

See also:Market cap,P/S ratio,ROE (return on equity),Debt to equity,Current ratio,All ratios

Common questions about Biogen's P/E ratio

Source: Financial Modeling Prep